Effects of Germline and Somatic Events in Candidate BRCA-like Genes on Breast-Tumor Signatures

Authors

Weston R. Bodily, Brigham Young University
Brian H. Shirts, University of Washington
Tom Walsh, University of Washington
Suleyman Gulsuner, University of Washington
Mary-Claire King, University of Washington
Alyssa Parker, Brigham Young University
Moom Roosan, Chapman UniversityFollow
Stephen R. Piccolo, Brigham Young University

Document Type

Article

Publication Date

9-30-2020

Abstract

Mutations in BRCA1 and BRCA2 cause deficiencies in homologous recombination repair (HR), resulting in repair of DNA double-strand breaks by the alternative non-homologous end-joining pathway, which is more error prone. HR deficiency of breast tumors is important because it is associated with better responses to platinum salt therapies and PARP inhibitors. Among other consequences of HR deficiency are characteristic somatic-mutation signatures and gene-expression patterns. The term “BRCA-like” (or “BRCAness”) describes tumors that harbor an HR defect but have no detectable germline mutation in BRCA1 or BRCA2. A better understanding of the genes and molecular events associated with tumors being BRCA-like could provide mechanistic insights and guide development of targeted treatments. Using data from The Cancer Genome Atlas (TCGA) for 1101 breast-cancer patients, we identified individuals with a germline mutation, somatic mutation, homozygous deletion, and/or hypermethylation event in BRCA1, BRCA2, and 59 other cancer-predisposition genes. Based on the assumption that BRCA-like events would have similar downstream effects on tumor biology as BRCA1/BRCA2 germline mutations, we quantified these effects based on somatic-mutation signatures and gene-expression profiles. We reduced the dimensionality of the somatic-mutation signatures and expression data and used a statistical resampling approach to quantify similarities among patients who had a BRCA1/BRCA2 germline mutation, another type of aberration in BRCA1 or BRCA2, or any type of aberration in one of the other genes. Somatic-mutation signatures of tumors having a non-germline aberration in BRCA1/BRCA2 (n = 80) were generally similar to each other and to tumors from BRCA1/BRCA2 germline carriers (n = 44). Additionally, somatic-mutation signatures of tumors with germline or somatic events in ATR (n = 16) and BARD1 (n = 8) showed high similarity to tumors from BRCA1/BRCA2 carriers. Other genes (CDKN2A, CTNNA1, PALB2, PALLD, PRSS1, SDHC) also showed high similarity but only for a small number of events or for a single event type. Tumors with germline mutations or hypermethylation of BRCA1 had relatively similar gene-expression profiles and overlapped considerably with the Basal-like subtype; but the transcriptional effects of the other events lacked consistency. Our findings confirm previously known relationships between molecular signatures and germline or somatic events in BRCA1/BRCA2. Our methodology represents an objective way to identify genes that have similar downstream effects on molecular signatures when mutated, deleted, or hypermethylated.

Comments

This article was originally published in PLoS ONE, volume 15, issue 9, in 2020. https://doi.org/10.1371/journal.pone.0239197

Recommended Citation

Bodily WR, Shirts BH, Walsh T, Gulsuner S, King M-C, Parker A, et al. (2020) Effects of germline and somatic events in candidate BRCAlike genes on breast-tumor signatures. PLoS ONE 15(9): e0239197. https://doi.org/10.1371/journal.pone.0239197

Copyright

The authors

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.